Paper Details

  1. Home
  2. Paper Details

[New therapeutic strategies and current research in inoperable locally advanced non small-cell lung cancers (stage IIIB)].

Author: ArriagadaR, BaldeyrouP, BretelJ J, GirardP, GrunenwaldD, Le CesneA, Le ChevalierT

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Treating inoperable locally advanced non-small cell lung cancer (NSCLC) remains challenging, with only a small percentage of patients surviving five years. While chemotherapy combined with radiation has shown some benefit compared to radiation alone, the five-year survival rate remains low. New, more intensive chemotherapy regimens and radiation schedules have shown promising results in smaller studies, but these need to be confirmed in larger trials. Innovative therapies, such as radical surgery for initially inoperable tumors, and newer approaches like biotherapies, vaccines, and gene therapy, are being explored to improve outcomes for this challenging disease.
Paper Details　
Original Abstract of the Article :
Treatment of patients with inoperable locally advanced non small-cell lung cancer (NSCLC) remains disappointing with less of 5% of patients alive at 5 years. Both initial local control and circumvention of concomitant undetectable metastatic chemoresistant cells are the critical targets for the onco...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/9238166

データ提供：米国国立医学図書館（NLM）

Innovative Therapies for Inoperable Locally Advanced Non-Small Cell Lung Cancer

The vast desert of lung cancer research is a challenging landscape, with relentless sandstorms of treatment options constantly evolving. This study, like a caravan seeking new pathways, investigates the latest advancements in the treatment of [inoperable locally advanced non-small cell lung cancer (NSCLC)]. The researchers, like seasoned explorers, meticulously analyze the various treatment strategies and highlight the need for further investigation into more aggressive and innovative approaches. They emphasize the importance of combining conventional therapies with emerging biotherapies, including [recombinant cytokines, antitumoral vaccines, and gene therapy programs], to combat this aggressive disease. Their findings offer a glimmer of hope in the ongoing fight against lung cancer.

A New Oasis of Hope in the Desert of Lung Cancer

This research, like a beacon in the desert, illuminates the need for innovative and multi-faceted approaches to treating inoperable NSCLC. The exploration of emerging biotherapies, combined with conventional treatments, offers a promising path toward improving outcomes for patients facing this challenging diagnosis. It's a reminder that in the vast desert of cancer research, there are always new oases of hope waiting to be discovered.

Embracing Innovation in Cancer Treatment

This study encourages us to embrace innovation in cancer treatment. By exploring new technologies, combining different approaches, and collaborating across disciplines, we can create a more effective and hopeful oasis for patients battling this formidable disease. Remember, the desert of cancer research is constantly evolving, and with continued exploration and a steadfast commitment to innovation, we can find new pathways to recovery and a brighter future for patients.

Dr. Camel's Conclusion

This study reminds us that the desert of lung cancer research is vast and complex, demanding a multifaceted approach to treatment. The exploration of innovative therapies, including emerging biotherapies, offers a glimmer of hope in the fight against this challenging disease. By embracing a collaborative and innovative approach, we can create a more effective and hopeful oasis for patients facing this formidable challenge.

Date :
  1. Date Completed 1997-08-07
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

9238166

DOI: Digital Object Identifier

9238166

Related Literature

Article Analysis
・Effective treatment of lung cancer
SNS
PICO Info
in preparation
Languages

French

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.